Tuesday, April 2, 2024

May 2: Trade Secrets for In-House Counsel: Best Practices for Successfully Managing and Protecting Trade Secrets

Join us on Thursday, May 2, 2024 at 12pm ET / 9am PT for the next edition of our Deep Dives Series, as James Pooley, International Trade Secret Expert, Ray Miller, Partner, DLA Piper, and Chris Buntel, Co-Founder and CIPO, Tangibly, will discuss why trade secrets are vital to organizations, the laws governing them, and effective strategies for managing these assets to prevent loss and unauthorized disclosure.
Discussion topics include:
  • Trade Secret Management Strategies, including asset management, three factors for protection, and how to manage the human element
  • Trade Secret Risk Areas, including people, processes, and management,
  • Trade Secret case law updates, and more!
Who should attend:
In-house counsel and legal operations professionals in the life sciences industry who manage or are involved in the protection or management of Trade Secrets and/or other sensitive intellectual property.
Title:
Trade Secrets for In-House Counsel: Best Practices for Successfully Managing and Protecting Trade Secrets
Date+Time:
Thursday, May 2, 2024
12pm ET / 9am PT
Speakers:
  • Chris Buntel is an intellectual property attorney with over 20 years’ experience . He is a co-founder and the CIPO of Tangibly. Chris is passionate about trade secret management and education. He has a Ph.D. in Chemistry from Stanford University, and J.D. in Law from University of Houston.
  • Ray Miller is a trusted intellectual property advisor to clients in a wide range of spaces. He adds value to each client’s IP estate by providing clear and pragmatic guidance that allows for efficient navigation of IP opportunities. Ray helps clients identify, protect, secure and optimize the value of their IP by combining strategic patent prosecution with manufacturing and regulatory exclusivity strategies. Ray counsels materials science, pharmaceutical, medical device, biologics and digital therapeutics clients to allow them to obtain a sufficient return on their investment. Ray also manages freedom-to-operate, manufacturing and supply considerations on his clients’ behalf. His clients include private equity and venture capital funds, pharmaceutical and biotechnology firms, world-class medical and research facilities, and Fortune 500 companies with well-developed intellectual property portfolios. Ray’s practice is transactional. He has led hundreds of due diligence projects and prepared all forms of IP agreements and opinions. He applies his deep understanding of the life and materials sciences in a diverse range of industries such as pharmaceuticals, biotechnology, energy, manufacturing, computer hardware, water and air purification, and specialty plastics and chemicals. Ray’s experience in pharmaceuticals and biotechnology extends to disciplines such as medicinal chemistry, genetics, nutraceuticals, proteomics, nanotechnology and tissue engineering.
  • James Dooley frequently serves lead counsel in major trade secret litigation as an experienced and trustworthy advisor, a member of the team who combines his scholarship and practical experience to add unique value. Company counsel rely on Jim to help investigate and assess potential or ongoing disputes. Due to his unique background, his clients benefit not only from his expertise but also from the efficiency that comes with over forty years of practice in this field. Trade secret cases by their nature can be unpredictable and difficult to manage, so it helps to have a steady, independent source of seasoned advice. Jim can apply his independent perspective at any phase of a case, but may be particularly helpful as settlement counsel in mediation, allowing lead counsel to maintain the traditional role of advocate.
Credit:

No comments:

Post a Comment